Liraglutide effects on glycemic control and weight in patients with type 2 diabetes Mellitus: A real-world, observational study and brief narrative review-Reference-Cited by-同舟云学术

Liraglutide effects on glycemic control and weight in patients with type 2 diabetes Mellitus: A real-world, observational study and brief narrative review

Published:2021-07 Issue: Volume:177 Page:108871
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Yousef Consuela Cheriece,Thomas Abin,Matar Manar Al,Ghandoura Lama,Aldossary Ibrahim,Almuhanna Sarah Musa,Alhussain Fatimah,AL Bisher Fatmh Bisher,Aljohani Raneem Mohammad,Balubaid Alya Najeeb,Nouh Mahmoud Ismail,Almurashi Abdulhalim,AlAmoudi Reem

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference32 articles.

1. Type 2 diabetes;Chatterjee;Lancet,2017

2. Glycemic control and accompanying risk factors: 4-year primary care study;Ferwana;J Diabetes Metab,2015

3. A review of glycemic efficacy of liraglutide once daily in achieving glycated hemoglobin targets compared with exenatide twice daily, or sitagliptin once daily in the treatment of type 2 diabetes;Alshali;Saudi Med J,2016

4. The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia;Alzaheb;Diabetes Metab Syndrome Obesity Targets Therapy,2018

5. Incidence and prevalence rates of diabetes mellitus in Saudi Arabia: an overview;Alotaibi;J Epidemiol Glob Health,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon-like peptide-1 receptor agonist therapy effects on glycemic control and weight in a primary care clinic population;Journal of Investigative Medicine;2024-08-12

2. The Effect of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists on the Lipid Profile of Diabetic Patients Using Statins: A Retrospective Cohort Study in the Diabetic Center of King Salman Bin Abdulaziz Hospital, Saudi Arabia;Cureus;2024-07-27

3. Retinopathy risk factors in patients with type 2 diabetes on liraglutide;Medicine;2024-07-19

4. Effectiveness and Safety of Add-on Once-Daily Liraglutide (1.2 mg) in Type 2 Diabetes Patients with Obesity: Data from a Real-World Cohort of Iraqi Patients;Clinical Diabetology;2024-06-30

5. From hyperglycemia to intervertebral disc damage: exploring diabetic-induced disc degeneration;Frontiers in Immunology;2024-02-20